{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-297518","form_type":"8-K","ticker":"NERV","cik":"0001598646","company_name":"Minerva Neurosciences, Inc.","filed_at":"2022-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.355366+00:00","generated_at":"2026-06-21T10:15:40.733394+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Minerva Neurosciences receives Nasdaq notice for MVLS non-compliance; has until May 30, 2023","bullets":["Nasdaq notified Minerva on Dec 1, 2022 that MVLS fell below $35M for 30 consecutive business days.","Company has until May 30, 2023 to regain compliance by closing at $35M for ten consecutive business days.","No immediate delisting; stock continues trading on Nasdaq Capital Market under symbol NERV.","If not compliant by May 30, 2023, Nasdaq may delist; company may seek extension or appeal.","Company is evaluating options to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-297518","json":"https://secwatch.observer/filing/0001193125-22-297518.json","markdown":"https://secwatch.observer/filing/0001193125-22-297518.md","text":"https://secwatch.observer/filing/0001193125-22-297518.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522297518/0001193125-22-297518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522297518/d427491d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T10:15:40.733394+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"28fbb570b7887722420a4e6a75bac017654496d9","claim":"Minerva Neurosciences, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).","evidence_excerpt":"December 1, 2022, Minerva Neurosciences, Inc. (the “Company”) received notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the Company’s minimum Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided an initial period of 180 calendar days, or until May 30, 2023, to regain compliance. The letter states that the Nasdaq","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522297518/0001193125-22-297518-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5550(b)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}